Influence of donor cytomegalovirus (CMV) status on severity of viral reactivation after allogeneic stem cell transplantation in CMV-seropositive recipients

Clinical Infectious Diseases

Volumn 52, Issue 7, 2011, Pages

  Pietersma, Floor L ^a   Van Dorp, Suzanne ^a   Minnema, Monique C ^a   Kuball, Jürgen ^a   Meijer, Ellen ^b   Schuurman, Rob ^a   Van Baarle, Debbie ^a,b  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

THYMOCYTE ANTIBODY; VALACICLOVIR; VALGANCICLOVIR;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOCYTIC LEUKEMIA; ADULT; ALLOGENEIC STEM CELL TRANSPLANTATION; ANTIVIRAL THERAPY; APLASTIC ANEMIA; ARTICLE; CHRONIC LYMPHATIC LEUKEMIA; CHRONIC MYELOID LEUKEMIA; CONTROLLED STUDY; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; FEMALE; GRAFT RECIPIENT; HODGKIN DISEASE; HUMAN; HYPEREOSINOPHILIC SYNDROME; INFECTION PREVENTION; LYMPHOPROLIFERATIVE DISEASE; MAJOR CLINICAL STUDY; MALE; MULTIPLE MYELOMA; MYELODYSPLASTIC SYNDROME; MYELOFIBROSIS; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; VIRUS LOAD; VIRUS REACTIVATION;

CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; SEVERITY OF ILLNESS INDEX; STEM CELL TRANSPLANTATION; TISSUE DONORS; VIRUS ACTIVATION;

EID: 79953758894     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/cir002     Document Type: Article

References (12)

1. Boeckh M, Nichols WG, Papanicolaou G, et al. Cytomegalovirus in hematopoietic stem cell transplant recipients: current status, known challenges, and future strategies. Biol Blood Marrow Transplant 2003; 9:543-558. (Pubitemid 38351787)
2. Ozdemir E, Saliba RM, Champlin RE, et al. Risk factors associated with late cytomegalovirus reactivation after allogeneic stem cell transplantation for hematological malignancies. Bone Marrow Transplant 2007; 40:125-136. (Pubitemid 47046210)
3. Patel SR, Ridwan RU, Ortin M. Cytomegalovirus reactivation in pe-diatric hemopoietic progenitors transplant: a retrospective study on the risk factors and the efficacy of treatment. J Pediatr Hematol Oncol 2005; 27:411-415. (Pubitemid 41233295)
4. Ljungman P, Perez-Bercoff L, Jonsson J, et al. Risk factors for the development of cytomegalovirus disease after allogeneic stem cell transplantation. Haematologica 2006; 91:78-83. (Pubitemid 43235389)
5. Zhou W, Longmate J, Lacey SF, et al. Impact of donor CMV status on viral infection and reconstitution of multifunction CMV-specific T cells in CMV-positive transplant recipients. Blood 2009; 113: 6465-6476.
6. Ugarte-Torres A, Hoegh-Petersen M, Liu Y, et al. Donor serostatus impacts cytomegalovirus-specific immunity, cytomegaloviral disease incidence and survival in seropositive hematopoietic cell transplant recipients. Biol Blood Marrow Transplant 2010. E-pub ahead of print.
7. van Doornum GJ, Guldemeester J, Osterhaus AD, Niesters HG. Diagnosing herpesvirus infections by real-time amplification and rapid culture. J Clin Microbiol 2003; 41:576-680.
8. Meijer E, Spijkers S, Moschatsis S, et al. Active Epstein-Barr virus infection after allogeneic stem cell transplantation: re-infection or reactivation? Transpl Infect Dis 2005; 7:4-10. (Pubitemid 40978667)
9. Nichols WG, Boeckh M, Carter RA, Wald A, Corey L. Transferred herpes simplex virus immunity after stem-cell transplantation: clinical implications. J Infect Dis 2003; 187:801-808. (Pubitemid 36286941)
10. 1 T-cell immune recovery after allogeneic stem cell transplantation. Bone Marrow Transplant 2007; 39:293-299. (Pubitemid 46322636)
11. 1 T lymphocytes in T-cell-depleted stem cell grafts and after transplantation may identify patients at risk for progressive CMV infection. Blood 2001; 98:1358-1364.
12. Scheinberg P, Melenhorst JJ, Brenchley JM, et al. The transfer of adaptive immunity to CMV during hematopoietic stem cell transplantation is dependent on the specificity and phenotype of CMV-specific T cells in the donor. Blood 2009; 114:5071-5080.